Aker BioMarine — AGM Information 2021

Mar 23, 2021

Aker BioMarine – Amendments to the articles of association, including change of company name

Aker BioMarine – Amendments to the articles of association, including change of company name

Fornebu, 23 March 2021

Reference is made to the stock exchange announcement by Aker BioMarine AS (the "Company") on 12 March, regarding the minutes from the annual general meeting held on 12 March 2021.

The amendments to the Company's articles of association resolved by the annual general meeting, including the conversion of the Company into a Norwegian public limited liability company and change of company name to Aker BioMarine ASA, have now been registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret).

For further information, please contact Martin Stenshall, Investor Relations

Mobile: +47 47 33 83 31

Email: martin.stenshall@akerbiomarine.com

About Aker BioMarine

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Admitted to trading on Euronext Growth, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL® Aqua), and animal feed applications (QRILL® Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company’s strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. Read more: www.akerbiomarine.com